Radio and PodcastRadio and PodcastLive Radio & Podcasts
Tazemetostat Withdrawl and RECITE artwork
Science & Medicine

Tazemetostat Withdrawl and RECITE

OncoPharm by OncoPharmPod

Mar 19, 202600:14:47Science & Medicine

Tazemetostat is withdrawn from the market due to a risk of secondary malignancies. RECITE asks if romiplostim improves platelet counts for patients on oxaliplatin-based regimens with thrombocytopenia. Spoiler - yes it do...

About This Episode

Tazemetostat Withdrawl and RECITE is an episode from OncoPharm by OncoPharmPod. Tazemetostat is withdrawn from the market due to a risk of secondary malignancies. RECITE asks if romiplostim improves platelet counts for patients on oxaliplat...

Podcast

This episode belongs to OncoPharm.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Mar 19, 2026, 00:14:47 long, audio available.

Questions About This Episode

What is Tazemetostat Withdrawl and RECITE about?

Tazemetostat is withdrawn from the market due to a risk of secondary malignancies. RECITE asks if romiplostim improves platelet counts for patients on oxaliplatin-based regimens with thrombocytopenia. Spoiler - yes it does, but does that make a difference? Check out the Oncology Insights Newsletter:

Where can I listen to Tazemetostat Withdrawl and RECITE?

You can listen to Tazemetostat Withdrawl and RECITE online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is Tazemetostat Withdrawl and RECITE from?

Tazemetostat Withdrawl and RECITE is an episode from OncoPharm by OncoPharmPod.

How long is this episode?

This episode is 00:14:47 long.

When was this episode published?

This episode was published on Mar 19, 2026.

Can I save Tazemetostat Withdrawl and RECITE for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from OncoPharm?

Yes. This page shows related episodes from OncoPharm when more episodes are available from the podcast feed.